Q3 Earnings Alert! Plan early for this week’s stock reports with all key data in 1 placeSee list

Phreesia CEO Chaim Indig sells over $123k in company stock

Published 13-09-2024, 03:36 am
PHR
-

Phreesia, Inc.'s (NYSE:PHR) Chief Executive Officer, Chaim Indig, has recently sold shares of the company's common stock, according to the latest Form 4 filing with the Securities and Exchange Commission. The transaction, which occurred on September 10, involved the sale of 5,295 shares at a weighted average price of $23.25, amounting to a total value of $123,109.


The sales were executed in multiple transactions with prices ranging between $22.94 and $23.17 per share. This price range indicates a non-discretionary sale that was part of the company's mandatory sell-to-cover policy, which is designed to satisfy tax withholding obligations related to the settlement of restricted stock units.


Following the sale, Indig's direct holdings in Phreesia, Inc. have decreased, but he still owns a significant number of shares. Additionally, the filing revealed indirect ownership of 255,000 shares held by the Indig Dynasty Trust. This trust is advised by Indig's sister-in-law and benefits his immediate family members.


Investors often monitor insider transactions as they can provide insights into executives' perspectives on the company's financial health and future prospects. However, it is important to note that these transactions can be influenced by a variety of factors, including personal financial management, and may not necessarily reflect a change in the executive's outlook on the company.


The sale was officially signed off by Allison Hoffman by Power of Attorney for Chaim Indig on September 12, as per the document filed with the SEC.


In other recent news, Phreesia has been the focus of several financial firms following its Q2 results. The company's revenue increased year-over-year by 19%, and it reported a positive EBITDA of $7 million, surpassing the consensus estimate. This led to an upward revision of the EBITDA forecast for fiscal year 2025. Analyst firms Baird and Truist Securities increased their price targets for Phreesia based on these results, with Baird raising its target to $34 and Truist to $31, both maintaining positive ratings.


Phreesia also provided new guideposts for client growth and revenue per client for fiscal years 2025 to 2026, signaling a shift toward sustained profitable growth. Piper Sandler, Canaccord Genuity, and Needham maintained their respective price targets on Phreesia's shares, reiterating their confidence in the company's growth trajectory and operational strategy.


Furthermore, Phreesia anticipates an increase in Active Healthcare Service Clients (AHSCs) to 4,500 by the end of fiscal year 2026, up from 4,200 in fiscal year 2025. They also expect year-over-year growth in average revenue per user (ARPU), driven by larger initial contracts and enhanced ARPU among its existing client base. These are among the recent developments in Phreesia's financial performance and future growth indicators.


InvestingPro Insights


Phreesia, Inc. (NYSE:PHR) has been in the spotlight with its CEO's recent share sale, sparking interest in the company's financial health and future growth potential. In light of these events, key metrics and insights from InvestingPro offer additional context for investors evaluating the company's position.


Despite a challenging week where the stock took a notable 7.51% hit, Phreesia has shown a strong return over the last three months, with a 16.36% increase. This resilience may catch the eye of investors looking for companies with the ability to rebound from short-term volatility. In addition, the company's market capitalization stands at $1.37 billion, reflecting its standing in the market.


However, analysts following Phreesia have raised concerns, with the consensus indicating that the company is not expected to be profitable this year. This aligns with the current negative P/E ratio of -13.31, which suggests that investors are paying more for each dollar of loss the company incurs. Moreover, with a high Price / Book multiple of 5.36, the stock is trading at a premium compared to the company's book value, which could signal that it is overvalued or that investors have high expectations for future growth.


For investors seeking a deeper dive into Phreesia's financials and future outlook, InvestingPro offers additional InvestingPro Tips. Currently, there are 7 more tips available on the platform, which could provide further insights into the company's operational and financial strategies.


It's worth noting that Phreesia operates with a moderate level of debt and has not been profitable over the last twelve months, which may influence investment decisions. Additionally, the company does not pay a dividend, which could be a deciding factor for income-focused shareholders.


For those interested in a more comprehensive analysis, visiting InvestingPro for Phreesia at https://www.investing.com/pro/PHR can provide valuable information to help inform investment strategies.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.